Cambridge Angels is a group of more than 60 high net worth investors who have experience as successful entrepreneurs in technology, internet, software, hardware, and healthcare sectors. Members invest in and mentor early stage companies across the UK.
Cambridge Angels led the seed round with backing from Manchester Angels and NorthInvest.
"New 2D materials for membranes are needed to improve sustainability, accessibility and tackle one of the world's greatest problems – delivering clean fresh water for all."
The seed round was led by the UK Innovation & Science Seed Fund to support team expansion and product development.
"X-ray scanners are such a common technology that we don’t often think of them as an area for innovation. But the reality is that the addressable market is huge – far beyond the obvious medical applications, with X-ray equipment critical in a range of sectors from construction to manufacturing. Silveray’s technology could play a key role in bringing the world’s oldest imaging technology into the 21st century."
Angel Academe leads the investment into the artificial intelligence startup, with backing from Cambridge Angels and private investors.
The financing values the digital postage company at £4m and will support sales and product development.
Playfair Capital led the seed investment in Qureight, with backing from Meltwind, Ascension, and Cambridge Angels, to accelerate drug development partnerships.
"our next targets are pulmonary hypertension and adverse drug effects in complex lung cancer patients. This funding will allow us to use our platform to work with our biopharma partners to accelerate drug development in these areas."
